CA Patent

CA2892739A1 — Substituted tetracycline compounds for treatment of inflammatory skin disorders

Assigned to Paratek Pharmaceuticals Inc · Expires 2008-07-03 · 18y expired

What this patent protects

Methods and compositions for the treatment of skin disorders (e.g , acne, rosacea) are described.

USPTO Abstract

Methods and compositions for the treatment of skin disorders (e.g , acne, rosacea) are described.

Drugs covered by this patent

sarecycline-hydrochloride (SARECYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CA2892739A1
Jurisdiction: CA
Classification: —
Expires: 2008-07-03
Drug substance claim: No
Drug product claim: No
Assignee: Paratek Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.